Market Crash1

"The Field Where Lehman Died" Is About to Get Bloody Again

By Matt Piepenburg, Macro Signal Strategist, Money Morning • Friday, September 20, 2019

Cameras rolled as U.S. Federal Reserve Chair Jerome Powell dished out more accommodative rate cuts for his Wall Street masters on Wednesday...

... but he didn't say one word about the ongoing, extraordinary, and profoundly unsettling intervention in the "repo," or repurchasing markets.

We're three days into this silent crisis. It shows no signs of letting up. The Fed has pumped around $205 billion in emergency liquidity into this little-known but crucially important funding mechanism for banks - but it's been totally downplayed by the spinmeisters in the Marriner S. Eccles Building.

Folks, we're living through some of the most dangerous and dicey times since October 2008. And we deserve to know the truth about how thin the ice beneath our feet is.

Since we're not likely to get that from anyone in the D.C.-Wall Street pipeline, I'll lay out what's really going on here...

Here's What's Fueling Our Favorite Travel Stock of 2019

Peak vacation season may be cooling down, but that doesn’t mean the same for travel stocks. Travel tourism is one of the fastest-growing industries in the world right now, ahead of healthcare, finance, and even information technology. And today, we’re bringing you a travel stock that’s cemented its position atop the industry. Operating in over 230 countries and territories around the world, this company could see a windfall of profits in the coming months from trends in online booking.

But this stock could rise quickly, so you'll want to get in early...

Stocks

One of the Best Healthcare Stocks Is Poised to Break Out

Once again, our proprietary VQScore system has beaten analysts to the punch and identified an under-the-radar stock sitting right in the “Buy Zone.” This time, it’s a leading healthcare stock that owns almost 30% of the entire U.S. pharmacy-retail market. Now, it's recently taken a tumble from weak earnings reports and a botched merger. But don’t let those shortcomings fool you – the company is working on designs to revolutionize personal care with virtual reality and AI.

Investors who get in now could see big returns in the months ahead...